Sale!

MK677 (Ibutamoren)

(4 customer reviews)

$120.00

  • Gains in Lean Muscle Mass

  • Helps to increase REM sleep

  • Improved Bone Mineral Density

  • Fights Ageing

  • Increase Wound Healing Rate

Availability: 25 in stock (can be backordered)

Category:

What is MK 677?

MK 677 (Ibutamoren), is an over-the-counter, non-peptide. MK 677 is a supplement that promotes growth hormone and insulin-like growth factor 1(IGF1). It mimics a gherlin, a hormone in the brain to activate it’s receptors. This receptor singles the body to release more growth hormone throughout the body. It elevates the hormones’ plasma level, while leaving the body’s cortisol levels normal.

What has been MK 677 effects.

MK 677 is has show a high number of bodily benefits through clinical trials, some which have concluded, and some which are still ongoing. Many have documented the results of the MK 677 :

  • Gains in Lean Muscle Mass

  • Helps to increase REM sleep

  • Improved Bone Mineral Density

  • Fights Ageing

  • Increase Wound Healing Rate

Does MK 677 have side effects?

MK 677 does have a few side effects, mostly an increase in appetite.

Other side effects include lower extremity muscle pain, people with high GH level could have an increase insulin resistance, which could be problematic for diabetics.

It’s also possible that those suffering from cancer or Th1 dominant people could have their health conditions worsened, and should be avoided.

4 reviews for MK677 (Ibutamoren)

  1. Conrad V

    This has been a god send. Helped me get into a consistent sleep/gym/eat routine throughout the day.

  2. Tony (verified owner)

    It’s only been 1 month ..
    But form previous experience with mk677 another brand..
    Got the the usual side affects ,, slight numbness in hands,,, slight strength gains,,,, slight weight increase,,,,
    As it’s a long term slow acting supplement ,,,time will tell…but seems decent ,,,

  3. Sam H

    great!

  4. Taro (verified owner)

    Good

Add a review

Your email address will not be published. Required fields are marked *